ICY:FRA
Incyte Corp
€ १००.००
arrow_downward
-०.०५%(-०.०५०) 1D
अक्टोबर १२, २२:००:०० GMT+२ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ICY...
Open
€ १००.००
High
€ १००.००
Low
€ १००.००
Mkt. cap
२२.५७ अरब
Avg. vol.
३४.००
Volume
०.००
52-wk high
€ ११५.४०
52-wk low
€ ७२.२८
No. of employees
३ हजार
Open
€ १००.००
High
€ १००.००
Low
€ १००.००
Mkt. cap
२२.५७ अरब
Avg. vol.
३४.००
Volume
०.००
52-wk high
€ ११५.४०
52-wk low
€ ७२.२८
No. of employees
३ हजार
News stories
From web sources and news partners
TipRanks
·
१९ घण्टा पहिले
GEN İlaç Secures Exclusive Rights to Incyte Drugs in Türkiye and Azerbaijan
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees२.८४ हजार
Founded२००२
HeadquartersWilmington, डेलावेयर, संयुक्त राज्य अमेरिका
Sector-
Websiteincyte.com